SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol 1997; 145: 40815.
  • 2
    Petri M, Roubenoff R, Dallai GE, Nadeau MR, Selhub J, Rosenberg IH. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996; 348: 11204.
  • 3
    Boumpas DT, Austin HA III, Fessler BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995; 122: 94050.
  • 4
    Boumpas DT, Fessler BJ, Austin HA III, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 2: dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 1995; 123: 4253.
  • 5
    Petri M, Spence D, Bone LR, Hochberg MC. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients and preventative practices. Medicine (Baltimore) 1992; 71: 291302.
  • 6
    Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 5139.
  • 7
    Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valind S. Cardiovascular disease in systemic lupus erythematosus: a study of 75 patients from a defined population. Medicine (Baltimore) 1992; 71: 216223.
  • 8
    Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991; 21: 5564.
  • 9
    Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore) 1989; 68: 14150.
  • 10
    Ginzler EM, Shorn K. Outcome and prognosis in systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14: 5778.
  • 11
    Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. QJM 1985; 55: 8798.
  • 12
    Haider YS, Roberts WC. Coronary artery disease in systemic lupus erythematosus: quantification of degree of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 1981; 70: 77581.
  • 13
    Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976; 60: 2215.
  • 14
    Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975; 58: 24364.
  • 15
    Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335: 142430.
  • 16
    Toubi E, Khamashta MA, Panarra A, Hughes GRV. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995; 99: 397401.
  • 17
    Sibley JT, Olszynski WP, Decoteau WE, Sundarm MB. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 1992; 19: 4752.
  • 18
    Eustace S, Hutchinson M, Bresnihan B. Acute cerebrovascular episodes in systemic lupus erythematosus. QJM 1991; 81: 73950.
  • 19
    Kitagawa Y, Gotoh F, Koto A, Okayasu H. Stroke in systemic lupus erythematosus. Stroke 1990; 21: 15339.
  • 20
    Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke 1989; 20: 58391.
  • 21
    McDonald J, Stewart J, Urowitz MB, Gladman DD. Peripheral vascular disease in patients with systemic lupus erythematosus. Ann Rheum Dis 1992; 51: 5660.
  • 22
    Nencini P, Pracucci G, Lamassa M, Amaducci L, Inzitari D. Immunological factors predict a poor long-term outcome in young stroke patients [abstract]. Lupus 1994; 3: 314.
  • 23
    Crozier IG, Li E, Milne MJ, Nicholls MG. Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 1990; 65: 11458.
  • 24
    Leung WH, Wong KL, Lau CP, Wong CK, Cheng CH, Tai YT. Doppler echocardiographic evaluation of left ventricular diastolic function in patients with systemic lupus erythematosus. Am Heart J 1990; 120: 827.
  • 25
    Leung WH, Wong KL, Lau CP, Wong CK, Cheng CH. Cardiac abnormalities in systemic lupus erythematosus: a prospective M-mode, cross-sectional and Doppler echocardiographic study. Int J Cardiol 1990; 27: 36775.
  • 26
    Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 33846.
  • 27
    Abbott RD, McGee D. The Framingham study, section 37: the probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. Publication No. 887-2284. Washington, DC: National Institutes of Health; 1987.
  • 28
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 29
    Abrahamowicz M, du Berger R, Grover SA. Flexible modelling of the effects of serum cholesterol on coronary heart disease mortality. Am J Epidemiol 1997; 145: 71429.
  • 30
    West of Scotland Coronary Prevention Study Group. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 1998; 97: 14405.
  • 31
    Grover SA, Abrahamowicz M, Joseph L, Brewer C, Coupal L, Suissa S. The benefits of treating hyperlipidemia to prevent coronary heart disease: estimating changes in life expectancy and morbidity. JAMA 1992; 267: 81622.
  • 32
    Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation 1991; 83: 35662.
  • 33
    Wolfe PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke 1991; 22: 3128.
  • 34
    Durrington PN, Prais H, Bhatnagar D, France M, Crowley V, Khan J, et al. Indications for cholesterol-lowering medication: comparison of risk-assessment methods. Lancet 1999; 353: 27881.
  • 35
    Grover S. Role of WHO-MONICA project in unravelling of the cardiovascular puzzle [editorial]. Lancet 2000; 355: 6689.
  • 36
    Grover S, Coupal L, Hu X-P. Identifying adults at increased risk of coronary disease: how well do the current cholesterol guidelines work? JAMA 1995; 274: 8016.
  • 37
    Haq IU, Ramsey LE, Yeo WW, Jackson PR, Wallis EJ. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 1999; 81: 406.
  • 38
    Abrahamowicz M, Fortin PR, du Berger R, Nayak V, Neville C, Liang MH. The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials. J Rheumatol 1998; 25: 27784.
  • 39
    Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall; 1993.
  • 40
    Mackey AE, Abrahamowicz M, Langlois Y, Battista R, Simard D, Bourque F, et al, and the Asymptomatic Cervical Bruit Study Group. Outcome of asymptomatic patients with carotid disease. Neurology 1997; 48: 896903.
  • 41
    Lewis RF, Abrahamowicz M, Côté R, Battista RN. Predictive power of duplex ultrasonography in asymptomatic carotid disease. Ann Intern Med 1997; 127: 1320.
  • 42
    Côté R, Battista RN, Abrahamowicz M, Langlois Y, Bourque F, Mackey A, and the Asymptomatic Cervical Bruit Study Group. Lack of effect of aspirin in asymptomatic patients with carotid bruits and substantial carotid narrowing. Ann Intern Med 1995; 123: 64955.
  • 43
    Wilterdink JL, Easton JD. Vascular event rate in patients with atherosclerotic cerebrovascular disease. Arch Neurol 1992; 49: 85763.
  • 44
    Autret A, Pourcelot L, Saudeau D, Marchal C, Bertrand P, De Boisvilliers S. Stroke risk in patients with carotid stenosis. Lancet 1987; 1: 88890.
  • 45
    Nieto FJ. Cardiovascular disease and risk factor epidemiology: a look back at the epidemic of the 20th century. Am J Public Health 1999; 89: 2924.